Serial Number | 76344089 |
Word Mark | IMAGYNE |
Filing Date | Friday, November 30, 2001 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Saturday, July 11, 2009 |
Registration Number | 2656295 |
Registration Date | Tuesday, December 3, 2002 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, September 10, 2002 |
Goods and Services | Product research and development directed to delineating cellular signaling pathways underlying the pathological progression of disease |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Saturday, July 11, 2009 |
Primary Code | 042 |
First Use Anywhere Date | Friday, February 12, 1999 |
First Use In Commerce Date | Friday, February 12, 1999 |
Party Name | AGY Therapeutics, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Party Name | AGY Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Party Name | AGY Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Event Date | Event Description |
Saturday, July 11, 2009 | CANCELLED SEC. 8 (6-YR) |
Tuesday, June 17, 2008 | CASE FILE IN TICRS |
Tuesday, December 3, 2002 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, September 10, 2002 | PUBLISHED FOR OPPOSITION |
Wednesday, August 21, 2002 | NOTICE OF PUBLICATION |
Thursday, June 27, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, June 3, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 21, 2002 | NON-FINAL ACTION MAILED |
Friday, March 1, 2002 | ASSIGNED TO EXAMINER |
Thursday, February 28, 2002 | ASSIGNED TO EXAMINER |